John Bluth | SVP, IR and Corporate Communications |
Jon Stonehouse | CEO |
Anthony Doyle | CFO |
Charlie Gayer | Chief Commercial Officer |
Bill Sheridan | Chief Medical Officer |
Helen Thackray | Chief R&D Officer |
Ken Cacciatore | Cowen & Company |
Brian Cheng | Cantor Fitizgerald |
Liisa Bayko | Evercore ISI |
Jessica Fye | JPMorgan |
Serge Belanger | Needham & Company |
Tazeen Ahmad | Bank of America |
Jon Wolleben | JPM Securities |
Maury Raycroft | Jefferies |
Nicole Gabreski | Piper Sandler |
Brian Abrams | RBC Capital Markets |
Thank you for standing by, and welcome to the BioCryst's Second Quarter 2021 Earnings Call. Please note that all participants would be in listen-only mode until the question and answer session of today's conference. [Operator Instructions] Please also note that today's call is being recorded. I'll now turn the call over to your host John Bluth. Sir, you may now begin.